Saltar al contenido principal
TransparenciaAlgunas páginas de este sitio contienen enlaces de afiliados; podemos ganar una comisión si compra a través de ellos. Nuestras puntuaciones y clasificaciones siguen nuestra metodología publicada; las comisiones no influyen en ellas. Lea nuestra metodología →
ColinérgicoDosis clínica · 250–500mg/day (the memory trials in older adults used 1000–2000mg/day)Inicio de acción · Memory effects measured after 2–3 months; an acute 1–2 hour onset is unconfirmed for citicoline alone

Citicoline (CDP-Choline)

An RCT in healthy older adults (Spiers et al., 1996) found 1000mg/day improved delayed verbal recall in people with relatively inefficient memory, with 2000mg/day improving immediate and delayed recall. A 2023 meta-analysis found a positive effect on cognitive status in MCI and dementia, but rated study quality poor with a high risk of bias. The 2005 Cochrane review found benefit on memory and behaviour in older adults with chronic cerebral disorders but no evidence of benefit on attention. In acute ischemic stroke, a dose-response RCT (Clark 1997) found better functional outcomes, with 500mg the optimal dose.

Por el equipo editorial de The Nootropic LabActualizado 8 min de lectura✓ Datos verificados

Evidencia revisada el

Mecanismo de acción

Citicoline (cytidine 5'-diphosphocholine) is a precursor to both acetylcholine and phosphatidylcholine. It boosts acetylcholine synthesis in the brain — the neurotransmitter central to attention, learning, and memory encoding. It also supports neuronal membrane integrity by replenishing phospholipids.

Resumen de evidencia clínica

An RCT in healthy older adults (Spiers et al., 1996) found 1000mg/day improved delayed verbal recall in people with relatively inefficient memory, with 2000mg/day improving immediate and delayed recall. A 2023 meta-analysis found a positive effect on cognitive status in MCI and dementia, but rated study quality poor with a high risk of bias. The 2005 Cochrane review found benefit on memory and behaviour in older adults with chronic cerebral disorders but no evidence of benefit on attention. In acute ischemic stroke, a dose-response RCT (Clark 1997) found better functional outcomes, with 500mg the optimal dose.

Matriz de efectos en humanos

Basado solo en ensayos clínicos en humanos. Se excluyen los datos en animales e in vitro.

EfectoEvidenciaMagnitudEstudios
Attention & Focus mixta
Pequeño
2
Working Memory moderada
Moderado
2
Neuroprotection moderada
Moderado
1

Clave de evidencia: Sólida = varios ECA consistentes · Moderada = ECA más pequeños o menos numerosos · Preliminar = ensayos iniciales o n pequeño · Mixta = resultados contradictorios

Beneficios documentados

  • Verbal memory in older adults with weaker memory
  • Cognitive status in MCI and dementia (low-quality evidence)
  • Functional recovery after ischemic stroke (one RCT)

Efectos secundarios y precauciones

  • Very well tolerated — no drug-related serious adverse events in the stroke dose-response RCT
  • Rare: headache at very high doses
  • Insomnia if taken late in the day

Cómo tomarlo

Dosis250–500mg/day; the memory trials in older adults used 1000–2000mg/day, and 500mg was the optimal dose in the stroke trial
MomentoMorning — citicoline is mildly activating and can cause insomnia if taken after 2pm
Con comidaCan be taken with or without food. No significant difference in absorption. If you experience mild nausea, take with a small meal.
FormasCapsule. Two standardised branded forms exist: Cognizin (used in Mind Lab Pro) and Citicoline Sodium. Both are effective. Avoid generic unlabelled CDP-choline from unknown sources.

Recomendaciones de combinación

Ingredientes que se combinan bien con Citicoline (CDP-Choline) y por qué.

Citicoline handles acute attention and acetylcholine; Bacopa covers long-term memory consolidation. The combination addresses both short-term focus and long-term memory in one stack.

Citicoline provides cognitive activation; L-Theanine is often added for calm, though in a controlled caffeine trial (Rogers 2008) it did not significantly reduce jitteriness, and we cite no trial of this pairing.

Complementary timeframes: citicoline works acutely on acetylcholine; Lion's Mane works long-term on NGF. No mechanism overlap — a clean combination.

Preguntas frecuentes

Citicoline vs choline bitartrate — what is the difference?

Citicoline is significantly superior. It crosses the blood-brain barrier more efficiently and provides two active components: choline (for acetylcholine) and cytidine (which converts to uridine, a brain membrane building block). Choline bitartrate provides choline only and crosses the BBB poorly.

Should I split my dose?

At 250mg, a single morning dose is fine. At 500mg, some people split it into 250mg morning and 250mg early afternoon for smoother coverage. Avoid any dose after 2–3pm as the mildly activating effect can delay sleep onset.

I got a headache after taking citicoline — is this normal?

A headache from citicoline at standard doses (250–500mg) is unusual and may indicate you are sensitive to cholinergic compounds or already getting significant choline from diet/other supplements. Try reducing to 250mg and do not combine with Alpha-GPC or other choline sources on the same day.

Cognizin vs generic CDP-Choline — does the brand matter?

Cognizin is the most clinically validated form and is tested for purity. Generic CDP-Choline can be fine if sourced from reputable suppliers, but quality varies more. For critical cognitive work, the premium branded form is worth the marginal cost increase.

Principales stacks que contienen Citicoline (CDP-Choline)

Citicoline (CDP-Choline) en América Latina

Productos disponibles en América Latina

ANVISA / COFEPRIS / INVIMA

Nota regulatoria

Esta página es contenido editorial con fines educativos y no constituye consejo médico. Los suplementos alimenticios están regulados por agencias nacionales: la Agência Nacional de Vigilância Sanitária (ANVISA) en Brasil bajo RDC 243/2018, la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) en México, y el Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) en Colombia. En Argentina, la Disposición 2105/2022 de la Administración Nacional de Medicamentos, Alimentos y Tecnología Médica (ANMAT) prohíbe siete productos concretos de las marcas Newmind y PURENOOTROPICS (Noopept, F-Phenibut y Bacopa) — no recomendamos productos con Noopept ni F-Phenibut a lectores en Argentina. Aviso para lectores en Brasil: el 2 de julio de 2026, ANVISA informó que algunos péptidos inyectables promocionados en internet, entre ellos GHK-Cu, BPC-157, TB-500, CJC-1295 e ipamorelin, no están regularizados en ninguna categoría (alimento, medicamento, cosmético ni suplemento alimentario) y son ilegales para cualquier uso en salud, incluido el estético. No enlazamos ni recomendamos proveedores que realicen envíos de formulaciones inyectables a Brasil. Consulte siempre a un profesional de la salud calificado antes de comenzar cualquier suplemento. / This page is editorial and not medical advice. Supplements are regulated by national agencies: the Agência Nacional de Vigilância Sanitária (ANVISA) in Brazil, the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS) in Mexico, and the Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA) in Colombia. In Argentina, ANMAT Disposition 2105/2022 prohibits seven specific products of the Newmind and PURENOOTROPICS brands (Noopept, F-Phenibut and Bacopa) — we do not recommend products containing Noopept or F-Phenibut to Argentine readers. Brazil notice: on 2 July 2026, ANVISA stated that some injectable peptides promoted online, including GHK-Cu, BPC-157, TB-500, CJC-1295 and ipamorelin, are not regularised in any category (food, medicine, cosmetic or food supplement) and are illegal for any health use, including aesthetic use. We do not link to or recommend vendors that ship injectable formulations to Brazil. Consult a qualified healthcare professional before starting any supplement.

Fuentes (6)ampliar